Poorer sleep and later wake times are associated with poorer cognitive function in patients with Huntington’s disease. Although sleep and circadian rhythms may be potential targets for modifying ...
Morning Overview on MSN
New Huntington’s disease treatments show promise, but caution remains
A gene therapy called AMT-130 appears to be the first treatment to slow the progression of Huntington’s disease, an inherited and fatal neurological disorder that has resisted every previous attempt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results